8K5N
Discovery of Novel PD-L1 Inhibitors That Induce Dimerization and Degradation of PD-L1 Based on Fragment Coupling Strategy
Summary for 8K5N
Entry DOI | 10.2210/pdb8k5n/pdb |
Descriptor | Programmed cell death 1 ligand 1, 3-[(1~{S})-1-[6-methoxy-3-methyl-5-[[[(2~{S})-5-oxidanylidenepyrrolidin-2-yl]methylamino]methyl]pyridin-2-yl]oxy-2,3-dihydro-1~{H}-inden-4-yl]-2-methyl-~{N}-[5-[[[(2~{S})-5-oxidanylidenepyrrolidin-2-yl]methylamino]methyl]pyridin-2-yl]benzamide (3 entities in total) |
Functional Keywords | immune checkpoint, dimer, small molecule inhibitor, immune system |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 30075.37 |
Authors | Cheng, Y.,Xiao, Y.B. (deposition date: 2023-07-22, release date: 2024-01-03, Last modification date: 2024-01-10) |
Primary citation | Wang, K.,Zhang, X.,Cheng, Y.,Qi, Z.,Ye, K.,Zhang, K.,Jiang, S.,Liu, Y.,Xiao, Y.,Wang, T. Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. J.Med.Chem., 66:16807-16827, 2023 Cited by PubMed: 38109261DOI: 10.1021/acs.jmedchem.3c01534 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report